Terapi target Dokter Terbaik di Israel - TOP-22 dokter

Dr. Pelles Sharon adalah ahli onkologi terkemuka dengan pengalaman luas dalam terapi target dan perawatan kanker tingkat lanjut lainnya di Sourasky Medical Center.

• Spesialisasi dalam terapi target untuk berbagai jenis kanker
• Berkontribusi pada penelitian klinis tentang sikap pasien onkologi terhadap uji klinis
• Melakukan berbagai perawatan kanker tingkat lanjut termasuk terapi SIRT dan HIPEC
• Bekerja di Sourasky Medical Center (Ichilov), rumah sakit terkemuka di Israel

Profesor Ofer Merimsky memimpin unit Onkologi Jaringan Lunak dan Tulang di Sourasky Medical Center – spesialis sarkoma terkemuka Israel.

• Pengalaman 30+ tahun merawat sarkoma dengan terapi tertarget
• Fellowship (Program Spesialisasi) di bidang sarkoma di Institut Gustave Roussy, Paris
• Anggota fakultas ESMO untuk penelitian sarkoma
• Telah menerbitkan banyak karya tentang onkologi ortopedi
• Mantan Ketua Masyarakat Onkologi Israel

Dr. Sarid telah menerbitkan lebih dari 30 artikel tentang terapi kanker dan memimpin uji klinis dalam pengobatan target di Sourasky Medical Center.

• Berspesialisasi dalam kemoterapi, radioterapi, dan terapi biologis untuk berbagai jenis kanker
• Lebih dari 15 tahun sebagai onkolog senior di Ichilov Medical Center
• Dosen di Tel Aviv University – terus mengikuti terapi terbaru
• Anggota ESMO dan ASCO – mengikuti pedoman perawatan internasional

Spesialis Ginekologi Onkologi dan Radioterapi di Sourasky Medical Center (Ichilov) dengan fokus pada terapi target.

• Berpengalaman dalam perawatan presisi untuk kanker ginekologi
• Menggunakan teknik radioterapi canggih untuk pengobatan yang ditargetkan
• Bagian dari tim onkologi terkemuka di pusat medis terbaik

Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.

She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.

Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.

Prof. Amit Tirosh is a senior endocrinologist and Head of the Neuroendocrine Tumors Service at Sheba Medical Center. He specializes in neuroendocrine tumors (NETs).

His work centers on hereditary NET syndromes. He is affiliated with the NIH in MEN1 research. He serves on an international VHL expert panel and helped write VHL management guidelines. He is the primary contact at Sheba’s multidisciplinary VHL clinic.

He leads the Endocrine Oncology Bioinformatics Lab. He collaborates with international teams, including the Weizmann Institute. He provides advanced NET care, including PRRT.

He earned his MD from the Hebrew University–Hadassah. He completed a residency at Assaf HaRofeh, an endocrinology fellowship at Rabin, and training at the NIH. He is board-certified in Endocrinology. He is a member of the Israeli Society of Endocrinology, the Endocrine Society, and the European Neuroendocrine Tumor Society. He has authored over 40 peer-reviewed papers, including in JAMA, Gastroenterology, and Radiology.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Dr. Raphael memimpin Inisiatif Kedokteran Genomik Nasional Israel dan memelopori uji coba terapi target di Sourasky Medical Center.

• Spesialisasi dalam keganasan toraks dan profil genomik komprehensif
• Peneliti utama untuk berbagai uji klinis imunoterapi
• Moderator Molecular Tumor Board untuk Israeli Lung Cancer Society
• Penerima hibah penelitian ESMO dan IASLC
• Mengembangkan teknik biopsi cair untuk pemantauan pengobatan

Dr. Ido Wolf memimpin Divisi Onkologi Medis di Sourasky Medical Center, berspesialisasi dalam terapi bertarget.

• Kepala Divisi Onkologi Medis di rumah sakit terkemuka Israel
• Pengalaman luas dalam onkologi dan penyakit dalam
• Pelatihan di Ben Gurion University of the Negev
• Latar belakang termasuk layanan di Unit Medis Angkatan Darat

Direktur Layanan Neuro-onkologi di Sourasky Medical Center – Dr. Blumental membawa keahlian khusus selama puluhan tahun di bidang neuro-onkologi.

• Pelatihan di Memorial Sloan-Kettering Cancer Center
• Neuro-onkolog senior sejak 1998
• Sebelumnya mengepalai Layanan Neuro-onkologi di Huntsman Cancer Institute

Dr. Dror Levin berspesialisasi dalam pengobatan kelainan darah dan kanker tulang pada anak-anak di Sourasky Medical Center, salah satu rumah sakit terkemuka di Israel.

• Direktur departemen hematologi onkologi anak di Sourasky Medical Center
• Mengoordinasikan pengobatan kanker tulang (sarkoma) pada anak-anak
• Pelatihan di Rizzoli Orthopaedic Institute di Italia – pemimpin dunia
• Anggota ISPHO (Masyarakat Hematologi Onkologi Anak Israel)

Dr. Fredi Aviv membawa 31 tahun keahlian terfokus dalam onkohematologi di Pusat Medis Sourasky.

• Berspesialisasi dalam perawatan kanker bertarget untuk gangguan darah
• Bekerja di Klinik Ichilov – pusat terkemuka untuk onkologi hematologi
• Pengalaman luas dengan pendekatan terapeutik baru

Direktur rawat inap onkologi di Pusat Medis Tel Aviv, Ichilov – Dr. Stepfansky memimpin tim perawatan kanker.

• Pengalaman lebih dari 20 tahun dalam onkologi dan penyakit dalam
• Peneliti dalam berbagai fase uji klinis di bidang onkologi
• Berspesialisasi dalam penyakit dalam dan onkologi di Ichilov

Dr. Amir berspesialisasi dalam terapi bertarget dengan Keytruda (Pembolizumab) untuk kanker payudara, didukung oleh lebih dari 30 presentasi dalam pertemuan ilmiah.

• Dianugerahi Penghargaan Penelitian Translasi Kanker Payudara ESMO pada tahun 2013
• Pelatihan fellowship di Institut Jules Bordet dan Emory University
• Anggota Masyarakat Onkologi Medis Eropa (ESMO)
• Penelitian yang diterbitkan diakui dua kali dengan Penghargaan Makalah Terbaik ISCORT Tahun Ini

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Dr. Eytan Aharon Ben‑Ami, MD, is a Senior Physician in the Sarcoma and Bone Oncology Service at Sheba Medical Center. He heads the Oncology Division and the Early-Phase Clinical Trials Unit. He founded the Sheba Clinical Research Organization. He is an academic affiliate at Tel Aviv University.

He specializes in sarcomas and primary bone tumors, including soft tissue sarcoma, liposarcoma, leiomyosarcoma, and osteosarcoma. He leads Phase I trials in targeted therapy and immunotherapy. He designs personalized treatment plans for rare cancers. He also develops patient-centered programs, including pilots in advanced immunotherapy delivery.

He completed a fellowship in Sarcoma and Bone Oncology at the Dana-Farber Cancer Institute/Harvard Cancer Center. He has authored more than 40 publications on early detection, molecular and viral mechanisms, and new cancer therapies.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.